Key Market Indicators
Sales of beta blocking medicine in Ireland are expected to reach approximately $20 million by 2026. In 2021, the market was worth $24 million, representing a 3.1% decrease on the average year-on-year rate since 2013. Ireland was the 16th-largest market in 2021, behind Finland at $24 million. Italy, Canada and Australia came in second, third and fourth, respectively.
